[{"address1": "1200 Avenue of the Americas", "address2": "Suite 200", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "332 255 9818", "website": "https://imux.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical trial, for treatment of multiple sclerosis, including relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company is also developing IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.", "fullTimeEmployees": 85, "companyOfficers": [{"maxAge": 1, "name": "Dr. Duane D. Nash J.D., M.B.A., M.D.", "age": 52, "title": "Executive Chairman", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 504570, "exercisedValue": 0, "unexercisedValue": 5500}, {"maxAge": 1, "name": "Dr. Daniel  Vitt Ph.D.", "age": 55, "title": "CEO & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 869959, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Glenn  Whaley CPA", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 576850, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andreas  Muehler M.D., Ph.D.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 694863, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jason  Tardio M.B.A.", "age": 46, "title": "COO & President", "yearBorn": 1977, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Hella  Kohlhof", "age": 49, "title": "Chief Scientific Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jessica  Breu", "title": "Head of Investor Relations & Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Inderpal  Singh", "age": 56, "title": "General Counsel", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Patrick  Walsh", "age": 39, "title": "Chief Business Officer", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Werner  Gladdines", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 7, "shareHolderRightsRisk": 6, "overallRisk": 7, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.4, "open": 1.39, "dayLow": 1.35, "dayHigh": 1.42, "regularMarketPreviousClose": 1.4, "regularMarketOpen": 1.39, "regularMarketDayLow": 1.35, "regularMarketDayHigh": 1.42, "beta": 1.839, "forwardPE": -1.7792208, "volume": 127398, "regularMarketVolume": 127398, "averageVolume": 309056, "averageVolume10days": 246150, "averageDailyVolume10Day": 246150, "bid": 1.34, "ask": 1.39, "bidSize": 100, "askSize": 400, "marketCap": 123408232, "fiftyTwoWeekLow": 0.945, "fiftyTwoWeekHigh": 1.92, "fiftyDayAverage": 1.34072, "twoHundredDayAverage": 1.290855, "currency": "USD", "enterpriseValue": 47367624, "floatShares": 52159353, "sharesOutstanding": 90079000, "sharesShort": 2515278, "sharesShortPriorMonth": 2954937, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0279, "heldPercentInsiders": 0.07724, "heldPercentInstitutions": 0.62575, "shortRatio": 8.61, "shortPercentOfFloat": 0.028199999, "bookValue": 0.706, "priceToBook": 1.94051, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -95305000, "trailingEps": -1.5, "forwardEps": -0.77, "pegRatio": -0.09, "lastSplitFactor": "1:40", "lastSplitDate": 1555286400, "enterpriseToEbitda": -0.506, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "IMUX", "underlyingSymbol": "IMUX", "shortName": "Immunic, Inc.", "longName": "Immunic, Inc.", "firstTradeDateEpochUtc": 1397741400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9418eda4-bdb2-33d3-9268-92e0d8463b7a", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.37, "targetHighPrice": 28.0, "targetLowPrice": 5.0, "targetMeanPrice": 11.9, "targetMedianPrice": 10.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 79698000, "totalCashPerShare": 0.885, "ebitda": -93532000, "totalDebt": 955000, "quickRatio": 3.581, "currentRatio": 3.747, "debtToEquity": 1.502, "returnOnAssets": -0.66802, "returnOnEquity": -1.4347, "freeCashflow": -42507752, "operatingCashflow": -72339000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]